Sphingolipid Metabolism in the Pathogenesis of Hashimoto’s Thyroiditis
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262110674 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jialiang Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Acupuncture and Massage, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China. Hauptthemen laut MEDLINE: Hashimoto Disease, Sphingolipids. Die Arbeit nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan Provincial Natural Science Foundation Project.
Abstract (Originalsprache)
Hashimoto’s thyroiditis (HT) is the most common autoimmune thyroid disorder, characterized by progressive lymphocytic infiltration, follicular destruction, tissue fibrosis, and an elevated risk of thyroid carcinoma. While the precise mechanisms underlying HT remain incompletely defined, emerging evidence implicates dysregulated sphingolipid (SPL) metabolism, particularly the sphingosine-1-phosphate (S1P) signaling axis, as a central contributor to disease pathogenesis. S1P, a bioactive lipid mediator, integrates metabolic and immunological cues to regulate immune cell trafficking, cytokine production, apoptosis, and fibroblast activation. Aberrant activation of the sphingosine kinase (SPHK)/sphingosine-1-phosphate (S1P)/S1P receptor (S1PR) pathway has been linked to persistent T helper 1 (Th1) cell recruitment, signal transducer and activator of transcription 3 (STAT3)-mediated immune polarization, epithelial–mesenchymal transition, extracellular matrix remodeling, and the establishment of a chronic inflammatory and fibrotic microenvironment. Moreover, S1P signaling may foster a pro-tumorigenic niche, providing a mechanistic explanation for the strong epidemiological association between HT and papillary thyroid carcinoma. This review summarizes current insights into the role of SPL metabolism in HT, highlighting its potential as a mechanistic link between autoimmunity, fibrosis, and carcinogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Acupuncture and Massage, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
ORCID-Profile: Jialiang Huang, Zeping Chen
Förderung
- Sichuan Provincial Natural Science Foundation Project
Zitieren
APA
Huang, J., Chen, Z., Wang, Y., Shang, C., & Feng, Y. (2025). Sphingolipid Metabolism in the Pathogenesis of Hashimoto’s Thyroiditis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110674
Vancouver
Huang J, Chen Z, Wang Y, Shang C, Feng Y. Sphingolipid Metabolism in the Pathogenesis of Hashimoto’s Thyroiditis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110674
BibTeX
@article{Huang2025,
author = {Huang, Jialiang and Chen, Zeping and Wang, Yijue and Shang, Chuyu and Feng, Yue},
title = {Sphingolipid Metabolism in the Pathogenesis of Hashimoto’s Thyroiditis},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262110674}
}
EUVIMED